| Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia LJ Russell, M Capasso, I Vater, T Akasaka, OA Bernard, MJ Calasanz, ... Blood, The Journal of the American Society of Hematology 114 (13), 2688-2698, 2009 | 583 | 2009 |
| Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report … L Hertzberg, E Vendramini, I Ganmore, G Cazzaniga, M Schmitz, ... Blood, The Journal of the American Society of Hematology 115 (5), 1006-1017, 2010 | 386 | 2010 |
| Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL A Van der Veer, E Waanders, R Pieters, ME Willemse, ... Blood, The Journal of the American Society of Hematology 122 (15), 2622-2629, 2013 | 321 | 2013 |
| Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) T Akasaka, T Balasas, LJ Russell, K Sugimoto, A Majid, R Walewska, ... Blood 109 (8), 3451-3461, 2007 | 233 | 2007 |
| Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial HM Ensor, C Schwab, LJ Russell, SM Richards, H Morrison, D Masic, ... Blood, The Journal of the American Society of Hematology 117 (7), 2129-2136, 2011 | 183 | 2011 |
| Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features CJ Schwab, L Chilton, H Morrison, L Jones, H Al-Shehhi, A Erhorn, ... Haematologica 98 (7), 1081, 2013 | 179 | 2013 |
| IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia AV Moorman, C Schwab, HM Ensor, LJ Russell, H Morrison, L Jones, ... J Clin Oncol 30 (25), 3100-3108, 2012 | 149 | 2012 |
| Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia V Rand, H Parker, LJ Russell, C Schwab, H Ensor, J Irving, L Jones, ... Blood, The Journal of the American Society of Hematology 117 (25), 6848-6855, 2011 | 144 | 2011 |
| Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations TD Buitenkamp, R Pieters, NE Gallimore, A van der Veer, JPP Meijerink, ... Leukemia 26 (10), 2204-2211, 2012 | 132 | 2012 |
| A new recurrent translocation t (11; 14)(q24; q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia E Chapiro, LJ Russell, S Struski, H Cave, I Radford-Weiss, VD Valle, ... Leukemia 24 (7), 1362-1364, 2010 | 110 | 2010 |
| IGH@ translocations are prevalent in teenagers and young adults with acute lymphoblastic leukemia and are associated with a poor outcome LJ Russell, A Enshaei, L Jones, A Erhorn, D Masic, H Bentley, KS Laczko, ... J Clin Oncol 32 (14), 1453-1462, 2014 | 100 | 2014 |
| IGH@ translocations are prevalent in teenagers and young adults with acute lymphoblastic leukemia and are associated with a poor outcome LJ Russell, A Enshaei, L Jones, A Erhorn, D Masic, H Bentley, KS Laczko, ... J Clin Oncol 32 (14), 1453-1462, 2014 | 100 | 2014 |
| Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia E Chapiro, L Russell, I Radford-Weiss, C Bastard, M Lessard, S Struski, ... Blood 108 (10), 3560-3563, 2006 | 85 | 2006 |
| t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) LJ Russell, T Akasaka, A Majid, K Sugimoto, E Loraine Karran, I Nagel, ... Blood, The Journal of the American Society of Hematology 111 (1), 387-391, 2008 | 81 | 2008 |
| Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia E Chapiro, L Russell, E Lainey, S Kaltenbach, C Ragu, V Della-Valle, ... Leukemia 24 (3), 642-645, 2010 | 77 | 2010 |
| The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukaemia blasts HC Williams MT, Yousafzai YM, Elder A, Rehe K, Bomken S, Frishman-Levy L ... Blood 127, 1998-2006, 2016 | 75* | 2016 |
| A novel translocation, t (14; 19)(q32; p13), involving IGH@ and the cytokine receptor for erythropoietin LJ Russell, DG De Castro, M Griffiths, N Telford, O Bernard, ... Leukemia 23 (3), 614-617, 2009 | 72 | 2009 |
| Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2–harboring clones as main relapse-driving force in childhood ALL M Morak, A Attarbaschi, S Fischer, C Nassimbeni, R Grausenburger, ... Blood, The Journal of the American Society of Hematology 120 (26), 5134-5142, 2012 | 64 | 2012 |
| Characterisation of the genomic landscape of CRLF2‐rearranged acute lymphoblastic leukemia LJ Russell, L Jones, A Enshaei, S Tonin, SL Ryan, J Eswaran, S Nakjang, ... Genes, Chromosomes and Cancer 56 (5), 363-372, 2017 | 60 | 2017 |
| Treatment outcome of CRLF2 ‐rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP‐BFM and UK NCRI‐CCLG study groups A Attarbaschi, M Morak, G Cario, G Cazzaniga, HM Ensor, T Te Kronnie, ... British journal of haematology 158 (6), 772-777, 2012 | 47 | 2012 |
